Dr. Crandall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9930 Grubbs Rd
Wexford, PA 15090Phone+1 412-367-1199Fax+1 412-367-0216
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1976 - 1979- UPMC Medical EducationResidency, Internal Medicine, 1973 - 1976
George Washington University School of Medicine and Health SciencesClass of 1973
Certifications & Licensure
PA State Medical License 1975 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.Shannon Stockton, Paul Catalano, Steven J Cohen, Barbara A Burtness, Edith P Mitchell
The Oncologist. 2023-09-07 - 13 citationsPhase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal CancerBenedito A. Carneiro, Ramesh K. Ramanathan, Marwan Fakih, Smitha S. Krishnamurthi, Barry C. Lembersky
Clinical Colorectal Cancer. 2012-03-01 - 3 citationsA phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancerRajesh Sehgal, Barry C. Lembersky, K. K. Rajasenan, Theodore L. Crandall, Edward P. Balaban
Clinical Colorectal Cancer. 2011-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
